FDA allows marketing of first whole slide imaging system for digital pathology

April 12, 2017 – The U.S. Food and Drug Administration today permitted marketing of the Philips IntelliSite Pathology Solution (PIPS), the first whole slide imaging (WSI) system that allows for review and interpretation of digital surgical pathology slides prepared from biopsied tissue. This is the first time the FDA has permitted the marketing of a WSI system for these purposes. “The system enables pathologists to read tissue slides digitally in order to make diagnoses, rather than … (leggi tutto)